Molecular Screening In Blastic Plasmacytoid Dendritic Cell Neoplasms Reveals Mutations In TET2 and ASXL1 In The Majority Of Patients

被引：1
|
作者：
Kern, Wolfgang
Kuznia, Sabrina
Schnittger, Susanne
Haferlach, Claudia
Haferlach, Torsten
Kohlmann, Alexander
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2581.2581
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2581
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome
    Feng, Yue
    Liang, Haiping
    Han, Meining
    Luo, Xingchun
    Zhu, Yu
    Liu, Bei
    HEMATOLOGY, 2023, 28 (01)
  • [22] Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia
    Cui Y.
    Tong H.
    Du X.
    Li B.
    Gale R.
    Qin T.
    Liu J.
    Xu Z.
    Zhang Y.
    Huang G.
    Jin J.
    Fang L.
    Zhang H.
    Pan L.
    Hu N.
    Qu S.
    Xiao Z.
    Experimental Hematology & Oncology, 4 (1)
  • [23] TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
    Soyer, Nur
    Kaymaz, Burcin Tezcanli
    Ozkan, Melda Comert
    Aktan, Cagdas
    Kucukaslan, Ali Sahin
    Sahin, Fahri
    Kosova, Buket
    Saydam, Guray
    TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (02) : 174 - 178
  • [24] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
    A Tefferi
    Leukemia, 2010, 24 : 1128 - 1138
  • [25] Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
    Tefferi, A.
    LEUKEMIA, 2010, 24 (06) : 1128 - 1138
  • [26] Sole DNMT3A/TET2/ASXL1 Mutations Define a Distinct Clinical Trajectory for Patients with Clonal Hematopoiesis
    Patel, Shyam Ajay
    Gerber, William K.
    Zheng, Rena
    Khanna, Shrinkhala
    Hutchinson, Lloyd
    Cerny, Jan
    Dasilva, Brandon
    Zhang, Tian Y.
    Khedr, Salwa
    Selove, William
    Woda, Bruce
    Abel, Gregory A.
    Miron, Patricia Minehart
    Higgins, Anne
    Gerber, Jonathan M.
    BLOOD, 2023, 142
  • [27] Similarities and Differences of DNMT3A, TET2 and ASXL1 Mutations across Ccus, MDS and AML
    Huber, Sandra
    Hutter, Stephan
    Baer, Constance Regina
    Meggendorfer, Manja
    Hoermann, Gregor
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    BLOOD, 2024, 144 : 1820 - 1820
  • [28] Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations
    Segura-Diaz, Adrian
    Stuckey, Ruth
    Florido, Yanira
    Maria Gonzalez-Martin, Jesus
    Francisco Lopez-Rodriguez, Juan
    Sanchez-Sosa, Santiago
    Gonzalez-Perez, Elena
    Saez Perdomo, Maria Nieves
    del Mar Perera, Maria
    de la Iglesia, Silvia
    Molero-Labarta, Teresa
    Teresa Gomez-Casares, Maria
    Bilbao-Sieyro, Cristina
    CANCERS, 2020, 12 (04)
  • [29] MUTATIONS OF TET2, ASXL1, CBL AND IDH1 IN MYELOFIBROTIC TRANSFORMATION OF ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
    Aviles, L. Martinez
    Besses, C.
    Alvarez-Larran, A.
    Pons, A.
    Serrano, S.
    Bellosillo, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 403 - 403
  • [30] TET2 Mutations in a Cohort of Patients with Myeloproliferative Neoplasms Lacking a Molecular Marker
    Maria Martinez-Aviles, Luz
    Besses, Carlos
    Alvarez-Larran, Alberto
    Pons, Aina
    Serrano, Sergi
    Bellosillo, Beatriz
    BLOOD, 2009, 114 (22) : 1504 - 1505
12345